GlaxoSmithKline Plc(NYSE : GSK)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Pharmaceuticals Major
|JNJ||Johnson & Johnson||1.13%||171.90||0.7%||$1110.55m|
|MRK||Merck & Co., Inc.||1.31%||77.53||0.7%||$789.82m|
|LLY||Eli Lilly & Co.||2.12%||243.55||1.1%||$743.79m|
|BMY||Bristol-Myers Squibb Co.||0.57%||68.35||1.0%||$596.46m|
|CERE||Cerevel Therapeutics Holdings, Inc.||-0.76%||24.80||0.2%||$151.26m|
|NRXP||NRX Pharmaceuticals, Inc.||35.59%||22.31||0.0%||$136.02m|
|BHVN||Biohaven Pharmaceutical Holding Co. Ltd.||2.81%||126.37||0.0%||$93.63m|
|OGN||Organon & Co.||-3.59%||29.81||0.0%||$83.74m|
|RPRX||Royalty Pharma Plc||-0.40%||40.20||0.2%||$77.14m|
GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals; Pharmaceuticals R&D; Vaccines and Consumer Healthcare. The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Pharmaceuticals R&D segment focuses on science related to the immune system, the use of human genetics and advanced technologies, and is driven by the multiplier effect of Science x Technology x Culture. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastro intestinal, and skin health categories. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.